Picture of Celyad Oncology SA logo

CYAD — Celyad Oncology SA News Story

0.000.00%
be flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Celyad Oncology Receives About EUR 9.8 Million In Private Placement Commitments From Historical Shareholders

Aug 29 (Reuters) - Celyad Oncology SA  CYAD.BR :
    * CELYAD ONCOLOGY RECEIVES APPROXIMATELY EUR 9.8M IN PRIVATE
PLACEMENT COMMITMENTS FROM HISTORICAL SHAREHOLDERS
    * CAPITAL INCREASE WILL TAKE PLACE AT A SUBSCRIPTION PRICE
OF EUR
0.52 PER SHARE
    * COMPANY INTENDS TO USE NET PROCEEDS FROM PRIVATE PLACEMENT
TO
FUND RESEARCH AND DEVELOPMENT EXPENSES
    * INTENDS TO USE NET PROCEEDS TO FUND RESEARCH AND
DEVELOPMENT
EXPENSES, ADVANCE CURRENT PIPELINE OF PRECLINICAL CAR-T
CANDIDATES, TO DISCOVER AND DEVELOP ADDITIONAL PRECLINICAL
PRODUCT CANDIDATES
    * FORTRESS HAS COMMITTED TO SUBSCRIBE FOR AN ADDITIONAL
AMOUNT OF
EUR 7,750,000 IN THIS SECOND CAPITAL INCREASE

Source text for Eikon:  ID:nBw3s5xhwa 
Further company coverage:  CYAD.BR 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Celyad Oncology SA

See all news